Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_3

Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)

NCT05668455
completednot_applicable

Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye

NCT02908282
completedphase_2

Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

NCT01089608
completednot_applicable

Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section

NCT01741649

Clinical Trials (4)

Showing 4 of 4 trials
NCT05668455Phase 3

Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)

Recruiting
NCT02908282Not Applicable

Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye

Completed
NCT01089608Phase 2

Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

Completed
NCT01741649Not Applicable

Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4